Biographical Sketch
Andrew Morrison, MD, is an Assistant Professor of Neurology and a fellowship-trained neuroimmunologist at the University of Pittsburgh. Dr. Morrison specializes in the evaluation and management of multiple sclerosis as well as rare and atypical neuroinflammatory disorders. Beyond his primary clinical domain, his research extends to the history of early American neurology and the evolution of medical education in the United States. As a first generation college graduate, he is deeply committed to fostering equity in healthcare and academia through medical education reform and pre-collegiate mentorship initiatives designed for students historically underrepresented in STEM fields.
Education & Training
- Fellowship in Neuroinflammatory Disorders, Hospital of the University of Pennsylvania
- Residency in Neurology, Hospital of the University of Pennsylvania
- Internship in Internal Medicine, Hospital of the University of Pennsylvania
- Doctor of Medicine (M.D.), University of Pittsburgh School of Medicine
Specialized Areas of Clinical, Research and/or Education Interests
Dr. Morrison's primary clinical focus is the diagnosis and management of neuroinflammatory disorders, though he also maintains a general neurology practice. His academic interests include medical education and pre-collegiate mentorship of students underrepresented in STEM. His research interests include the evaluation and management of rare and atypical neuroinflammatory disorders, as well as studying the history of early neurology and medical education in the United States.
Board Certifications
Neurology, American Board of Psychiatry and Neurology
Professional Organization Membership
- American Academy of Neurology (AAN)
- American Neurological Association (ANA)
- Phi Beta Kappa Society
Honors & Awards
Dr. Harold L. Mitchell Prize for Excellence in Neurology, University of Pittsburgh School of Medicine
Selected Recent Publications
Morrison AA, Samudralwar RD, Berger JR. Rapidly Progressive and Relapsing Myelitis With Human T Lymphotropic Virus Type 1: A Case Report and Review of the Literature. Neurology: Neuroimmunology & Neuroinflammation. 2026;13(3):e200570.
Hutto SK, Balaban D, Rohm Z, Morrison AA, et al. Rituximab in pathologically confirmed sarcoidosis affecting the central nervous system: a multi-center retrospective study. Journal of Neurology. 2025;272(8):519. doi:10.1007/s00415-025-13209-7.
